About this trial
Total knee arthroplasty is associated with moderate to severe postoperative pain, which may delay mobilization and recovery. Multimodal analgesia including regional anesthesia techniques is widely used to improve outcomes. The adductor canal block (ACB) provides anteromedial knee analgesia but may not adequately cover the posterolateral region.
The biceps femoris short head (BiFeS) block is a novel motor-sparing regional anesthesia technique targeting the posterolateral capsule of the knee. This randomized controlled trial aims to compare the analgesic efficacy and functional outcomes of ACB combined with BiFeS block versus ACB alone in patients undergoing total knee arthroplasty.
The primary outcome is posterior knee pain at postoperative 6 hours. Secondary outcomes include pain scores within 48 hours, opioid consumption, early and late functional recovery, and opioid-related adverse effects.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
ASA I-III
Adult patients undergoing unilateral primary TKA
Planned spinal anesthesia
Written informed consent
Disqualifiers
Coagulopathy
Drug allergy
BMI > 35
Renal/hepatic failure
Trial design
Parallel
Treatments tested in this trial
Adductor Canal Block
Procedure/SurgeryUltrasound-guided adductor canal block performed with injection of local anesthetic into the adductor canal to block the saphenous nerve and provide postoperative analgesia following total knee arthroplasty.
Biceps Femoris Short Head Block
Procedure/SurgeryUltrasound-guided biceps femoris short head block performed with injection of local anesthetic between the biceps femoris short head and femur to target the posterolateral innervation of the knee for postoperative analgesia.
Sham Biceps Femoris Short Head Block
Procedure/SurgerySham ultrasound-guided biceps femoris short head block performed with injection of normal saline at the same anatomical location to maintain blinding without providing active analgesia.
Treatment groups
Trial outcomes
Primary outcomes
Posterior Knee Pain Intensity
Posterior knee pain assessed using the Numeric Rating Scale (NRS, 0-10), where 0 indicates no pain and 10 indicates worst imaginable pain.
Secondary outcomes
Postoperative Pain Intensity
Pain intensity at rest and during movement assessed using the Numeric Rating Scale (NRS, 0-10).
Total Opioid Consumption
Total opioid consumption measured from patient-controlled analgesia (PCA) device and additional opioid requirements, expressed in milligrams of morphine equivalent.
Rescue Analgesic Use
Requirement for additional analgesic medications (e.g., meperidine, paracetamol, ibuprofen) recorded as yes/no and total doses administered.
Functional Recovery
Functional recovery assessed by range of motion (ROM), quadriceps muscle strength, time to first ambulation, ability to walk 10 meters without assistance, and performance on the 5-times sit-to-stand test.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: